Loading...

Home
Stock
BBIO

BBIO News & Events

-

$

0.000

0.000(0.000%)

At close

0.000(0.000%)Aft-market

ET

$

0.000

0.000(0.000%)

At close

0.000(0.000%)Aft-market

ET

Overview Forecast Technical Valuation Financials Earnings Should I Buy News

Most Trusted AI Platform for Winning Trades

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

Home
Contact
About Us
Press

Markets

Market Analysis
Crypto
Market Movers
Stock Monitor
All US Stocks

AI Strategies

AI Stock Picker
Swing Trading
Quant AI Alpha Pick
CoinSwing
Daytrading Center
Crypto Radar
Patterns Detection

Resources

Blog
Tutorial
Help Center
Affiliate Program

Products

Chat With Tia
AI Screener
Backtest Playground
Featured Screeners
AI Earnings Calendar
Thematic Investing
Whales Auto Tracker

Tools

Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator

Features

Explore AI Stock Picker
Master Swing Trading
Discover QuantAI Alpha Pick
Follow Whales Auto Tracker
Navigate Daytrading Center
Learn Patterns Detection
Meet Financial AI Agent
Maximize AI Screener
Why Backtesting Playground
Forecast AI Earnings Prediction
Setup Stock Monitor
Deep Dive into Tech Analysis

News

Overview
Top News
Daily Market Brief
Earnings Analysis
Newswire
Stock News
Crypto News
Institution News
Congress News
Monitor News

Compare

TradingView
SeekingAlpha

BBIO News

NASDAQ 100 Pre-Market Indicator Rises 126.58 to 25,673.66

Jan 16 2026NASDAQ.COM

BridgeBio Pharma Prices $550M Convertible Notes Offering with $538.4M Net Proceeds Expected

Jan 16 2026seekingalpha

BridgeBio Pharma Prices $550 Million Convertible Notes Offering

Jan 16 2026NASDAQ.COM

BridgeBio Pharma Prices $550 Million Convertible Notes at 0.75% Interest Rate

Jan 16 2026Globenewswire

BridgeBio Pharma (BBIO) Plans $550 Million Convertible Notes Offering

Jan 14 2026seekingalpha

BridgeBio Reports $146 Million in Attruby Product Revenue for Q4 2025

Jan 12 2026Globenewswire

Morgan Stanley Initiates Belite Bio at Overweight with $191 Price Target

Jan 06 2026CNBC

BridgeBio to Host Investor Webinar on Achondroplasia Treatment Insights

Jan 02 2026Globenewswire

BBIO Events

an image of No data

No data

BBIO Monitor News

BridgeBio Reports Strong Revenue Growth for Attruby in Q4 2025

BridgeBio Pharma rises on market strength and technical indicator

BridgeBio Pharma Inc experiences decline amid market strength

BBIO.O Hits 52-Week High Amid Strong Demand

BBIO Earnings Analysis

an image of No Data

No Data

People Also Watch